86.53
0.37%
0.32
Handel nachbörslich:
86.53
Finanzdaten der Vaxcyte Inc-Aktie (PCVX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
-
|
- | - | - | - |
Operating Expenses
|
41.80%
114.47
|
196.68 | 113.03 | 87.15 | 71.19 |
Depreciation and Amortization |
11.11%
1.00
|
0.90 | 0.80 | 0.80 | 0.70 |
Operating Income/Loss |
41.80%
-114.47
|
-196.68 | -113.03 | -87.15 | -71.19 |
Income/Loss From Continuing Operations Before Tax |
47.44%
-95.02
|
-180.80 | -92.66 | -68.34 | -60.46 |
Income Tax Expense/Benefit |
-
|
- | - | - | - |
Income/Loss From Continuing Operations After Tax |
47.44%
-95.02
|
-180.80 | -92.66 | -68.34 | -60.46 |
Net Income/Loss
|
47.44%
-95.02
|
-180.80 | -92.66 | -68.34 | -60.46 |
Preferred Stock Dividends And Other Adjustments |
100.00%
-
|
442.93 | -185.33 | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
6,140%
111.69
|
1.7899 | 101.67 | 98.06 | 86.21 |
Diluted Average Shares |
6,140%
111.69
|
1.7899 | 101.67 | 98.06 | 86.21 |
Basic Earnings Per Share |
53.30%
-0.85
|
-1.82 | -0.91 | -0.70 | -0.70 |
Diluted Earnings Per Share |
53.30%
-0.85
|
-1.82 | -0.91 | -0.70 | -0.70 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
100.00%
-
|
442.93 | -185.33 | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):